Informações:
Falhas:
ID
45513
Descrição
Principal Investigator: Sami N. Malek, MD, University of Michigan Department of Internal Medicine, Division of Hematology-Oncology, Ann Arbor, MI, USA MeSH: Lymphoma, Follicular,Lymphoma, Non-Hodgkin https://www.ncbi.nlm.nih.gov/projects/gap/cgi-bin/study.cgi?study_id=phs000729 A cohort of follicular lymphoma cases had tumor cells purified from tissue samples after informed consent using flow cytometry. DNA was extracted from the cells, and samples were subjected to solution-based exome capture using the Illumina TruSeq Exome Enrichment Kit and the Illumina HiSeq 2000 platform.
Link
Palavras-chave
Versões (1)
- 13/12/2022 13/12/2022 - Simon Heim
Titular dos direitos
Sami N. Malek, MD, University of Michigan Department of Internal Medicine, Division of Hematology-Oncology, Ann Arbor, MI, USA
Transferido a
13 de dezembro de 2022
DOI
Para um pedido faça login.
Licença
Creative Commons BY 4.0
Comentários do modelo :
Aqui pode comentar o modelo. Pode comentá-lo especificamente através dos balões de texto nos grupos de itens e itens.
Comentários do grupo de itens para :
Comentários do item para :
Para descarregar formulários, precisa de ter uma sessão iniciada. Por favor faça login ou registe-se gratuitamente.
dbGaP phs000729 Follicular Lymphoma 2013 - Malek
Eligibility Criteria
- StudyEvent: SEV1
- Eligibility Criteria
- Subject ID, consent group, and affection status of participants with follicular lymphoma and involved in the "Solution-based exome capture and HiSeq2000-based massively parallel sequencing of Follicular Lymphoma" project.
- Subject ID, sample ID, and sample use variable obtained from participants with follicular lymphoma and involved in the "Solution-based exome capture and HiSeq2000-based massively parallel sequencing of Follicular Lymphoma" project.
- Subject ID, disease diagnosis, age onset, and sex of participants with follicular lymphoma and involved in the "Solution-based exome capture and HiSeq2000-based massively parallel sequencing of Follicular Lymphoma" project.
- Sample ID, body site where sample was obtained, analyte type, tumor status of sample, histological type of cancer, and method for tumor and normal cell purification of participants with follicular lymphoma and involved in the "Solution-based exome capture and HiSeq2000-based massively parallel sequencing of Follicular Lymphoma" project.
Similar models
Eligibility Criteria
- StudyEvent: SEV1
- Eligibility Criteria
- Subject ID, consent group, and affection status of participants with follicular lymphoma and involved in the "Solution-based exome capture and HiSeq2000-based massively parallel sequencing of Follicular Lymphoma" project.
- Subject ID, sample ID, and sample use variable obtained from participants with follicular lymphoma and involved in the "Solution-based exome capture and HiSeq2000-based massively parallel sequencing of Follicular Lymphoma" project.
- Subject ID, disease diagnosis, age onset, and sex of participants with follicular lymphoma and involved in the "Solution-based exome capture and HiSeq2000-based massively parallel sequencing of Follicular Lymphoma" project.
- Sample ID, body site where sample was obtained, analyte type, tumor status of sample, histological type of cancer, and method for tumor and normal cell purification of participants with follicular lymphoma and involved in the "Solution-based exome capture and HiSeq2000-based massively parallel sequencing of Follicular Lymphoma" project.
Name
Tipo
Description | Question | Decode (Coded Value)
Tipo de dados
Alias
Item Group
Inclusion and exclusion criteria
C1512693 (UMLS CUI [1,1])
C0680251 (UMLS CUI [1,2])
C0680251 (UMLS CUI [1,2])
Patients were enrolled between 2008 and 2012 into a lymphoma repository at the University of Michigan Comprehensive Cancer Center. The study procured patient material during times of clinically indicated lymphoma surgeries. This study also procured buccal swabs, peripheral blood and occasional bone marrow aspirates. Subclassifications of the follicular lymphomas by World Health Organization criteria were verified by a hematopathologist using histopathologic, cytologic, and immunophenotypic features.
Item
Patients were enrolled between 2008 and 2012 into a lymphoma repository at the University of Michigan Comprehensive Cancer Center. The study procured patient material during times of clinically indicated lymphoma surgeries. This study also procured buccal swabs, peripheral blood and occasional bone marrow aspirates. Subclassifications of the follicular lymphomas by World Health Organization criteria were verified by a hematopathologist using histopathologic, cytologic, and immunophenotypic features.
boolean
C0030705 (UMLS CUI [1,1])
C1512693 (UMLS CUI [1,2])
C0024299 (UMLS CUI [1,3])
C3847505 (UMLS CUI [1,4])
C1519799 (UMLS CUI [1,5])
C0392360 (UMLS CUI [1,6])
C0543467 (UMLS CUI [1,7])
C0200345 (UMLS CUI [1,8])
C0005954 (UMLS CUI [1,9])
C0229664 (UMLS CUI [1,10])
C0580344 (UMLS CUI [1,11])
C0024301 (UMLS CUI [1,12])
C0008902 (UMLS CUI [1,13])
C1301142 (UMLS CUI [1,14])
C1711411 (UMLS CUI [1,15])
C0334866 (UMLS CUI [1,16])
C1265900 (UMLS CUI [1,17])
C0428093 (UMLS CUI [1,18])
C4745253 (UMLS CUI [1,19])
C1512693 (UMLS CUI [1,2])
C0024299 (UMLS CUI [1,3])
C3847505 (UMLS CUI [1,4])
C1519799 (UMLS CUI [1,5])
C0392360 (UMLS CUI [1,6])
C0543467 (UMLS CUI [1,7])
C0200345 (UMLS CUI [1,8])
C0005954 (UMLS CUI [1,9])
C0229664 (UMLS CUI [1,10])
C0580344 (UMLS CUI [1,11])
C0024301 (UMLS CUI [1,12])
C0008902 (UMLS CUI [1,13])
C1301142 (UMLS CUI [1,14])
C1711411 (UMLS CUI [1,15])
C0334866 (UMLS CUI [1,16])
C1265900 (UMLS CUI [1,17])
C0428093 (UMLS CUI [1,18])
C4745253 (UMLS CUI [1,19])